World Insurance Network

Peptide Insurance Programs

Peptide Insurance for Medical Practices and Clinics

A liability program built for physician practices and clinics that purchase professional-use peptides wholesale and provide them to patients under an NPI number. The program consists of two separate policies: Peptide Products Liability written on a general liability form, and a standalone peptide malpractice policy designed to ride alongside your primary malpractice policy. Your primary malpractice policy is left untouched, and the peptide exposure that conventional carriers will not cover is transferred to a policy built for it.

The Practice’s Exposure

Two Exposures, One Patient

A practice that buys peptides wholesale and sells them to patients at retail takes on two distinct roles. As a clinician, it recommends the peptide and sets the protocol. As a seller, it becomes part of the product’s distribution chain, with the same product claims exposure as any distributor. A single adverse outcome can trigger claims against both roles at once.

Conventional malpractice carriers do not cover exposures arising from recommendations or advice involving non-FDA-approved peptides, and malpractice coverage generally does not respond to product exposure at all. A practice may discover that gap only after a claim is filed. Rather than altering the primary malpractice policy, which continues to protect the practice’s conventional operations, this program places the peptide exposure on a separate policy designed to transfer it.

Your purchase agreement with your distributor typically contains bilateral indemnification, with each party answering for what it controls. The distributor and manufacturer answer for the product as made. The practice answers for storage, handling, recommendations, and administration. The two policies in this program are built to insure the practice’s own liability for what it controls: products liability for storage and handling, and peptide malpractice for recommendations and administration.

  • Product claims.Bodily injury alleged to arise from a peptide your practice sold or administered, including product compromised while in your storage.
  • Professional claims.Injury alleged to result from a negligent recommendation, a dosing protocol, or a failure to screen for contraindications.
  • Medical director exposure.The physician who oversees the program can be named personally for the protocols and oversight behind it.
  • Malpractice gaps.Conventional malpractice policies do not cover exposures arising from non-FDA-approved peptides, and they do not respond to product exposure.

Coverages Included

What Does This Program Include?

The program consists of two separate policies, each written for a distinct exposure. Peptide Products Liability, written on a general liability form, responds when the peptide itself is alleged to have caused harm. The peptide malpractice policy responds when a patient alleges bodily injury caused by negligent advice on peptide use. Because many peptide claims involve both, carrying both policies helps ensure that each exposure has a policy designed to respond to it.

Policy 1: Peptide Products Liability (General Liability Form)

Pays damages and defense costs when a claim alleges that a peptide your practice sold or provided caused bodily injury. When a practice marks up product and sells it to patients, it becomes a seller in the chain, and this is the coverage that answers for that role.

How It Applies to Practices

  • Retail sales. A patient alleges injury from a peptide purchased from your practice for use at home.
  • Storage and handling. A patient alleges injury from product that was mishandled, mislabeled, or dispensed in error while in your practice’s care.
  • Product defects. A patient alleges contamination or potency variance that originated upstream, and the practice is named as the seller.
  • Batch events. Multiple injuries traced to the same defect, lot, or decision may be declared a single related claim, subject to one occurrence limit and one deductible.

Indemnification and Your Purchase Agreement

This policy responds to your practice’s own legal liability. It does not insure the indemnification promises in your purchase agreement. Your agreement with your distributor should place the product as made on the distributor and manufacturer, and storage, handling, recommendations, and administration on the practice. Because coverage follows your liability rather than the contract, the agreement should be limited to what your practice controls and reviewed with your broker or legal counsel before you sign.

Policy 2: Peptide Professional Liability (Malpractice)

A standalone malpractice policy that pays damages and defense costs when a patient alleges bodily injury caused by negligent advice on peptide use, including the recommendation, protocol, dosing, or administration guidance behind it, as distinct from a defect in the product itself.

How It Applies to Practices

  • Recommendations. Claims that a peptide was recommended for a patient for whom it was not appropriate.
  • Protocols and dosing. Claims that a dosing schedule, titration, or administration protocol was negligently designed or followed.
  • Screening and monitoring. Claims that the practice failed to screen for contraindications or to monitor the patient appropriately.
  • Medical director liability. Included in the peptide malpractice policy. It covers the medical director’s personal exposure for the protocols and oversight behind the program.

Works With Your Existing Malpractice

This policy is written to ride alongside your primary malpractice policy, not replace it. The primary policy is left untouched so that it continues to protect the conventional operational exposures it was designed for. Because conventional malpractice carriers do not cover non-FDA-approved peptide exposures, a separate policy is used to transfer that particular exposure to a carrier that will insure it.

To include medical director coverage, select it on the application.

Additional Coverages Within the Policy

  • Sexual abuse liability with its own dedicated limit
  • Network security and data privacy liability, with first-party privacy breach expenses
  • HIPAA proceedings
  • Regulatory wrongful acts and license defense before a state board
  • Media activities, subpoena assistance, and peer review expenses
  • Reputation protection, lost wages for time spent in proceedings, and other supporting coverages, each subject to its own sublimit

Why the Two Policies Are Written Together

The peptide malpractice policy requires that general liability coverage, including products and completed operations, be in place. Policy 1 satisfies that requirement, so the two policies are designed to be carried together.

Claim Spotlight

What a Peptide Claim Looks Like for a Practice

Product claim

To save patients a second visit, front-desk staff assemble take-home kits containing vials, diluent, and syringes. Two peptides with similar vial labels are stocked side by side, and a patient’s kit is packed with the wrong one. The patient follows the instructions, injects a peptide that was never recommended, and suffers a serious adverse reaction. The claim alleges the practice dispensed the wrong product and names the practice as the seller.

Professional claim

A physician recommends a growth hormone-releasing peptide protocol for recovery and body composition. The patient’s history of poorly controlled diabetes is noted at intake, but no baseline labs are drawn and blood glucose is never monitored. Several weeks into the protocol, the patient is hospitalized with severe hyperglycemia. The suit alleges negligent advice and a failure to screen and monitor. It names the practice and the physician, and the medical director who approved the protocol is named personally.

$80,000–$150,000

Typical legal fees in the first 365 days of a product liability claim, before any settlement or judgment

2×

Legal expense when the same incident triggers a malpractice claim alongside the product claim, which it most likely will

For a practice, these scenarios rarely stay separate. When a patient is injured by a peptide the practice both recommended and sold, the product claim will most likely be accompanied by a malpractice claim. That doubles the legal expense in the matter, and those costs sit outside whatever a settlement or the indemnification language in your purchase agreement may dictate. A malpractice policy that excludes peptides, or does not respond to product exposure, leaves the practice to fund both defenses itself.

Transfer the risk to the carrier. Few practices can absorb six figures in legal fees in a single year, let alone a settlement on top of it. The two policies in this program transfer both the product and the peptide malpractice exposure to the insurance carrier, which funds your defense and pays covered damages up to the policy limits. Because defense costs are paid within the limits, choosing adequate limits matters as much as having the coverage in place.

Talk to a Broker

Typical Limits

Peptide Products Liability

$1,000,000 Each Claim / $3,000,000 Policy Aggregate

Peptide Malpractice

Professional Liability: $1,000,000 Each Claim / $3,000,000 Aggregate

Sexual Abuse: $1,000,000 Each Claim / $1,000,000 Aggregate

Each policy carries its own limits. Defense costs are included within the limits. Additional coverages on the malpractice policy are subject to separate sublimits. Deductibles and pricing are determined by underwriting based on revenue, services, and product profile.

Understanding Your Policy

Claims-Made Coverage
The policy responds to claims first made during the policy period for injury that occurred on or after your retroactive date. Renewing without a gap preserves protection for patients you have already served.
Retroactive Date
The earliest date of injury the policy will recognize. Keeping it unchanged at renewal, or when changing carriers, protects the care and product you have already provided.
Extended Reporting Period
If coverage ends, a basic reporting period applies automatically. Optional extensions of 12 to 60 months can be bought so that later claims from earlier care remain covered.
Defense Within Limits
Legal fees are paid from the policy limit, so each dollar spent on defense reduces the amount available for settlement. This is one reason to choose limits carefully.
No Exclusions by Peptide Type
Eligibility depends on labeling, sourcing, and physician oversight, not on which peptide is involved. Every peptide you offer should still be disclosed on the application.

Eligibility

Who Is Eligible?

Requirements

  • Physician practices and clinics with a licensed physician overseeing peptide use
  • Products labeled “For Professional Use Only”
  • Product sourced from a reputable manufacturer or distributor, not the open market
  • Product provided to patients through the medical channel under the practice’s or practitioner’s NPI number

Not Eligible

  • Research Use Only (RUO) peptides used clinically or sold outside the physician channel, and any direct-to-consumer sales.

Med spas adding peptide services are insured under our Med Spa program. Ask a broker which program fits your practice.

Talk to a Broker

Tell us what you need covered. A broker will review your request and respond during normal business hours.

Talk to a Broker